Public procurement notice: Contract Award Notice
Published: 2025-01-16
Buyer: SYKEHUSINNKJØP HF
Country: NO
Region: NO074
Contract type: Supplies
Procedure: Negotiated without a prior call for competition
CPV classification: 33600000: Pharmaceutical products
Estimated value: 24000000 NOK
Submission deadline: 2027-01-31
Award criteria: price, quality

Technical requirements: Sykehusinnkjøp HF, division pharmaceuticals, is collecting tenders for medicines that are used by the health authorities. It has previously been announced and held an open tender contest, 2501b Medicines not injection/infusion, where the competition included active substance in accordance with the tender documentation's Annex 2 Price Form. After the competition, tenders have been submitted for the following eye droplets: Cyklopentolat Minims 10mg/ml, ATC S01FA04, sub-contract 1004Tropikamid Minims 5mg/ml, ATC S01FA06, sub-contract 1005 Metoxedrin Minims 100mg/ml, ATC S01FB01, sub-contract 1008Oxibuprokain Minims 4mg/ml, ATC S01HA03, sub-contract 1010Tetrakain Minims 10mg/ml, ATC S01HA03, sub-contract 1011Artelac, ATC S01XA20, sub-contracts 1023 and 1024Viscotears, ATC S01XA20,  Sub-contract 1026Kloramfenikol Minims 5mg/ml, ATC S01AA01, sub-contract 1031Th there were no other tenderers in this competition for the relevant sub-contracts. Based on this, the division of medicinal products intends to enter into agreement between the regional health authorities (the Contracting Authorities) and Bausch & Lomb Nordic AB (the Supplier) in the contract 2501b Medicines not injection/infusion, i.e. the extent and length of the agreement shall follow the mentioned procurement (including access to prolongation and termination), without a new competition being announced for this active ingredientHealth companies that are subject to the regional health authorities have an option. to join the contracts. The same applies to ideal institutions/hospitals with operational agreements with each health region. Division pharmaceuticals has examined the market situation and assesses that it is not possible with a new competition or that another supplier can deliver the product in the pending contract period, and that the situation that has arisen is conditions that are not due to the contracting authorities or that the contracting authorities could predict. Sykehusinnkjøp, division pharmaceuticals therefore believes that it is necessary to implement the procurement without competition. See the public procurement regulations § 13-4 letter b no. 3. Sykehusinnkjøp requests tenderers who may object to this intention by the end of the waiting period, which is set to 29.01.2025. If objections are not received, contracts will be signed after the waiting period expires.
Sykehusinnkjøp HF, division pharmaceuticals, is collecting tenders for medicines that are used by the health authorities. It has previously been announced and held an open tender contest, 2501b Medicines not injection/infusion, where the competition included active substance in accordance with the tender documentation's Annex 2 Price Form. In the aftermath of the competition, tenders have been submitted for various eye droplets (ATC S01).
When the Contract period expires, the Contracting Authority can extend all or parts of the Contract for up to 1 year at a time. The total maximum agreement period is 4 years.


Number of bids: 1